Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,992 | -18,229 | -7,089 | -28,476 | -18,360 |
| Depreciation Amortization | -644 | -401 | -277 | -459 | -106 |
| Accounts receivable | 4,468 | 4,338 | 789 | -4,231 | -1,083 |
| Accounts payable and accrued liabilities | -942 | -1,715 | -4,729 | 2,280 | 249 |
| Other Working Capital | 6,455 | 2,620 | -3,451 | -1,653 | -2,758 |
| Other Operating Activity | -1,352 | -1,628 | 4,473 | 3,469 | 1,839 |
| Operating Cash Flow | $-25,007 | $-15,015 | $-10,284 | $-29,070 | $-20,219 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 28,590 | 40,030 | 18,145 | -59,680 | -47,044 |
| PPE Investments | -100 | -35 | -14 | -139 | -110 |
| Investing Cash Flow | $28,490 | $39,995 | $18,131 | $-59,819 | $-47,154 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 377 | 377 | 377 | N/A | N/A |
| Debt Repayment | -377 | -377 | -377 | N/A | N/A |
| Common Stock Issued | 5 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 138,434 | 0 | 0 | 96,676 | 96,676 |
| Financing Cash Flow | $138,439 | $N/A | $N/A | $96,676 | $96,676 |
| Beginning Cash Position | 15,425 | 15,425 | 15,425 | 7,638 | 7,638 |
| End Cash Position | 157,347 | 40,405 | 23,272 | 15,425 | 36,941 |
| Net Cash Flow | $141,922 | $24,980 | $7,847 | $7,787 | $29,303 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,007 | -15,015 | -10,284 | -29,070 | -20,219 |
| Capital Expenditure | -100 | -35 | -14 | -139 | -110 |
| Free Cash Flow | -25,107 | -15,050 | -10,298 | -29,209 | -20,329 |